Abstract
We assumed that a recovery of thrombopoiesis after intensive chemotherapy for acute myelogenous leukemia (AML) could reduce the need for prophylactic platelet transfusions. We therefore assessed the start of platelet production by means of daily determination of reticulated platelets (RP). The increase in RP occurred on day 20 (median) after the start of chemotherapy and was followed by a rise of peripheral platelet counts 2–3 days thereafter. Consequently, a rise of RP during the period of recovery can be regarded as representing the reconstitution of the peripheral platelet count and may reduce or eliminate the need for prophylactic platelet transfusions.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: December 10, 1998 / Accepted: March 3, 1999
Rights and permissions
About this article
Cite this article
Stohlawetz, P., Stiegler, G., Höcker, P. et al. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions. Ann Hematol 78, 271–273 (1999). https://doi.org/10.1007/s002770050513
Issue Date:
DOI: https://doi.org/10.1007/s002770050513